Back to top
more

IDEXX Laboratories (IDXX)

(Delayed Data from NSDQ)

$650.06 USD

650.06
798,784

+25.87 (4.14%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $650.31 +0.25 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (147 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is IDEXX Laboratories, Inc. (IDXX) Outperforming Other Medical Stocks This Year?

    Zacks Equity Research

    BSX or BAX: Which is a Better Pick for Your Portfolio Now?

    by Zacks Equity Research

    After considering various parameters and fundamentals, we help you make a choice between Boston Scientific (BSX) and Baxter (BAX).

      Zacks Equity Research

      Should You Invest in the First Trust Water ETF (FIW)?

      by Zacks Equity Research

      Sector ETF report for FIW

        Zacks Equity Research

        Why You Should Add IDEXX (IDXX) Stock to Your Portfolio?

        by Zacks Equity Research

        IDEXX's (IDXX) stellar performance is primarily driven by robust sales at the CAG (Companion Animal Group) business.

          Zacks Equity Research

          IDEXX Laboratories (IDXX) Up 6.4% Since Earnings Report: Can It Continue?

          by Zacks Equity Research

          IDEXX Laboratories (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

            Zacks Equity Research

            Time to Focus on IDEXX Laboratories (IDXX) for Strong Earnings Growth Potential

            by Zacks Equity Research

            IDEXX Laboratories (IDXX) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

              Zacks Equity Research

              IDEXX's (IDXX) Catalyst Uptake Remains Strong & Boosts CAG

              by Zacks Equity Research

              Solid organic growth trend within IDEXX's (IDXX) CAG revenues to sustain on the back of a strong global placement of high-premium Catalyst instruments.

                Zacks Equity Research

                Should You Invest in the First Trust Water ETF (FIW)?

                by Zacks Equity Research

                Sector ETF report for FIW

                  Zacks Equity Research

                  IDEXX (IDXX) Hits a 52-Week High, Can the Run Continue?

                  by Zacks Equity Research

                  IDEXX Laboratories, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for IDXX for clues.

                    Zacks Equity Research

                    IDEXX Laboratories (IDXX) Earnings, Revenues Rise in Q1

                    by Zacks Equity Research

                    IDEXX (IDXX) rides on strength in CAG business in Q1. A raised EPS guidance buoys optimism.

                      Zacks Equity Research

                      Zacks.com highlights: Louisiana-Pacific, IDEXX Laboratories, SolarEdge Technologies, Curtiss-Wright and Autohome

                      by Zacks Equity Research

                      Zacks.com highlights: Louisiana-Pacific, IDEXX Laboratories, SolarEdge Technologies, Curtiss-Wright and Autohome

                        Zacks Equity Research

                        IDEXX Laboratories (IDXX) Beats on Q1 Revenues, View Upbeat

                        by Zacks Equity Research

                        IDEXX Laboratories (IDXX) gains on solid contributions from Companion Animal Group business in Q1.

                          Zacks Equity Research

                          Invest in These 5 Low Leverage Stocks to Earn Steady Returns

                          by Zacks Equity Research

                          With the Q1 earnings season in full swing right now, investors should target low-leveraged stocks exhibiting solid earnings growth.

                            Zacks Equity Research

                            Can CAG Growth for IDEXX (IDXX) Stock Return in Q1 Earnings?

                            by Zacks Equity Research

                            IDEXX (IDXX) might repeat its gain streak in CAG for Q1, earlier driven by strong double-digit growth in reference labs and consumables plus a high-single-digit rise in rapid assay sales.

                              Zacks Equity Research

                              LeMaitre Vascular (LMAT) Soars to a 52-Week High, Time to Cash Out?

                              by Zacks Equity Research

                              LeMaitre Vascular, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for LMAT for clues.

                                Zacks Equity Research

                                The Zacks Analyst Blog Highlights: Seagate Technology, Micron Technology, IDEXX Laboratories, Kohl's and Motorola Solutions

                                by Zacks Equity Research

                                The Zacks Analyst Blog Highlights: Seagate Technology, Micron Technology, IDEXX Laboratories, Kohl's and Motorola Solutions

                                  Tirthankar Chakraborty headshot

                                  5 Top-Performing S&P 500 Stocks of Q1

                                  by Tirthankar Chakraborty

                                  We have highlighted five S&P 500 stocks that have dished out double-digit returns in Q1 and remained undisturbed by higher bouts of volatility

                                    Zacks Equity Research

                                    Why Should You Add IDEXX (IDXX) Stock to Your Portfolio?

                                    by Zacks Equity Research

                                    IDEXX (IDXX) might gain from the commercial launch of Catalyst SDMA Test in North America. As a result, its point-of-care customers can add SDMA as an essential element to the routine chemistry panel.

                                      Zacks Equity Research

                                      IDEXX Laboratories Gains on Solid Prospects & CAG Business

                                      by Zacks Equity Research

                                      IDEXX Laboratories (IDXX) continues to boost investor confidence in strong companion animal business along with attractive global prospects.

                                        Zacks Equity Research

                                        Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now

                                        by Zacks Equity Research

                                        IDEXX Laboratories (IDXX) continues to boost investor confidence on strong companion animal business along with growth across all segments.

                                          Zacks Equity Research

                                          Zacks.com featured highlights include: Lululemon, Exelixis, IDEXX, Teradyne and Pioneer Natural

                                          by Zacks Equity Research

                                          Zacks.com featured highlights include: Lululemon, Exelixis, IDEXX, Teradyne and Pioneer Natural

                                            Tirthankar Chakraborty headshot

                                            5 of the Best Efficient Stocks for Your Portfolio

                                            by Tirthankar Chakraborty

                                            Companies with a favorable efficiency level are expected to provide impressive returns as efficiency is believed to be positively correlated with price performance.

                                              Zacks Equity Research

                                              Second Sight (EYES) Catches Eye: Stock Jumps 12.7%

                                              by Zacks Equity Research

                                              Second Sight (EYES) saw a big move last session, as its shares jumped nearly 13% on the day, amid huge volumes.

                                                Zacks Equity Research

                                                IDEXX Laboratories Strong on CAG Business Amid Currency Woes

                                                by Zacks Equity Research

                                                IDEXX's (IDXX) innovation-based global strategy is leading to growth at CAG Diagnostics.

                                                  Zacks Equity Research

                                                  IDEXX Laboratories (IDXX) Beats on Q4 Earnings and Revenues

                                                  by Zacks Equity Research

                                                  IDEXX (IDXX) rides high on strength in CAG business in Q4. A raised guidance buoys optimism.